Antimicrobial Activity of WCK 4282 (High-Dose Cefepime-Tazobactam) Tested against Gram-negative Organisms from Medical Centers Located in Europe and the Asia-Pacific Region
Antimicrobial Activity of WCK 4282 (High-Dose Cefepime-Tazobactam) Tested against Gram-negative Organisms from Medical Centers Located in Europe and the Asia-Pacific Region, Lead author: Sader HS, presented at 26th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 9-12, 2016, Amsterdam, Netherlands
